Side-by-side comparison of AI visibility scores, market position, and capabilities
$2.3B raised at $29.3B valuation; $2B+ ARR (Q1 2026); used by 50%+ of Fortune 500. Dominant commercial AI coding tool; built on VSCode fork with native agent mode. Competing with GitHub Copilot, Windsurf, and Lovable in the vibe-coding wave.
Cursor is an AI-first code editor founded in 2022 by a small team of MIT researchers, built as a fork of Visual Studio Code with native large-language-model intelligence woven directly into the editing experience. Its mission is to make software engineers dramatically more productive by embedding AI reasoning into every layer of the IDE — from autocomplete to multi-file edits to natural-language code generation — rather than bolting AI on as an afterthought.\n\nThe platform centers on a VSCode-compatible editor that developers can adopt with zero workflow disruption, layering in features like Tab (predictive multi-line completion), Chat (context-aware in-editor assistant), and Composer (autonomous multi-file refactoring agent). Cursor reads and indexes entire codebases, allowing it to propose changes that span dozens of files coherently. It supports all major languages, integrates with existing extensions, and lets teams configure which underlying model — GPT-4o, Claude, or others — powers suggestions. Fortune 500 engineering teams adopt it alongside individual developers, and it is used by more than half of Fortune 500 companies.\n\nCursor reached $2 billion in annualized recurring revenue by early 2026 and raised at a $29.3 billion valuation, cementing its position as the dominant commercial AI coding tool. The company raised $2.3 billion in total funding and is widely regarded as the category-defining product in agentic IDE software, outpacing GitHub Copilot on developer mindshare metrics in multiple surveys.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.